Cupid Ltd

Cupid Ltd

₹ 95.9 -1.76%
12 Jun - close price
About

Established in 1993, CUPID Limited is India's premier manufacturer of male and female condoms, personal lubricant, and IVD kits.[1]

Key Points

Products Offered[1]
The Co. manufactures male condoms, female condoms, water-based lubricant jelly, IVD products such as Pregnancy Test Kits, Covid 19 Antigen Test Kit, HIV Test Kit, Dengue test kits, Malaria antigen test kits, etc.

  • Market Cap 2,574 Cr.
  • Current Price 95.9
  • High / Low 114 / 50.0
  • Stock P/E 63.0
  • Book Value 12.8
  • Dividend Yield 0.00 %
  • ROCE 16.9 %
  • ROE 12.7 %
  • Face Value 1.00

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 7.52 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoters have pledged 40.5% of their holding.
  • Earnings include an other income of Rs.19.7 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Dec 2023 Mar 2024 Sep 2024 Dec 2024 Mar 2025
28 31 48 42 34 34 37 40 63 42 46 56
20 21 35 33 25 27 33 28 32 31 35 43
Operating Profit 9 10 13 9 9 7 4 12 31 10 11 13
OPM % 30% 33% 28% 22% 25% 20% 12% 30% 49% 25% 24% 24%
0 0 0 0 0 0 0 1 3 6 4 5
Interest 0 0 0 0 0 0 0 0 1 1 0 1
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax 8 9 13 8 8 6 4 12 32 14 14 16
Tax % 24% 24% 25% 23% 25% 24% 32% 24% 26% 29% 21% 28%
6 7 10 6 6 4 2 9 24 10 11 12
EPS in Rs 0.22 0.27 0.36 0.24 0.22 0.17 0.09 0.33 0.89 0.37 0.41 0.43
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2024 Mar 2025
149 171 184
108 121 142
Operating Profit 41 50 42
OPM % 28% 29% 23%
0 7 20
Interest 0 2 2
Depreciation 3 3 4
Profit before tax 38 53 55
Tax % 24% 24% 25%
29 40 41
EPS in Rs 1.09 1.49 1.52
Dividend Payout % 21% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 3%
Stock Price CAGR
10 Years: 41%
5 Years: 61%
3 Years: 108%
1 Year: 1%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2024 Mar 2025
Equity Capital 13 13 27
Reserves 118 288 315
0 12 19
22 7 11
Total Liabilities 152 320 372
29 58 67
CWIP 1 0 6
Investments 48 147 103
74 114 196
Total Assets 152 320 372

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2024 Mar 2025
42 8 -11
-9 -80 45
-33 99 -1
Net Cash Flow 0 27 32

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2024 Mar 2025
Debtor Days 62 102 133
Inventory Days 100 96 226
Days Payable 73 0 7
Cash Conversion Cycle 89 198 352
Working Capital Days 200 438 410
ROCE % 17%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
45.06% 45.06% 45.06% 45.06% 45.06% 45.06% 45.06% 44.80% 44.80% 45.62% 42.51% 42.51%
0.65% 0.59% 0.58% 0.66% 0.45% 0.34% 0.45% 5.19% 5.97% 3.33% 3.14% 1.63%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.11%
54.28% 54.35% 54.36% 54.28% 54.49% 54.60% 54.49% 50.00% 49.24% 51.05% 54.34% 55.75%
No. of Shareholders 29,41429,02927,22626,33326,43428,15425,58233,76195,6391,12,2361,16,3741,23,379

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls